Raising money, publishing pivotal research, building valuable alliances, all for the improvement of people with motor-neuron diseases. Sidney Collin and De Oro Device’s NexStride is a game-changer indeed.
On part 2 of our conversation with Sidney Collin, co-founder and CEO of De Oro Devices, we learn more about the business end of things, as Sidney elucidates about the impact NexStride is creating, out in the real world.
Discover more at - https://www.howitsmed.com/
If you like what we do, follow us on Twitter!
Timestamps:
01:45-04:33 - Forming important relationships with physicians, and how that has helped to get NexStride to the people who need it the most.
04:34-06:20 - The importance of publishing research work, and the role it plays in building credibility of the product.
06:20-09:05 - Sidney elaborates on the hard numbers that De Oro Devices could influence with the work that they do.
09:05-12:44 - The difference between pitching to an angel investor and pitching to a VC.
12:45-16:15 - Establishing distribution and selling channels for NexStride, be it D2C, B2B, or via a third-party representative such as the VA.
16:15-19:20 - Sidney explains the reasons as to why she decided for her employees to work remotely full-time.
19:20-22:02 - Working in California and working in Texas - Sidney sheds light on the difference in work culture in the two states.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.